Uterine and ovarian metastases 28 years after the discovery of a breast carcinoma;Métastases utérines et ovariennes 28 ans après la survenue d'un cancer du sein

Presse Medicale

Volumn 32, Issue 2, 2003, Pages 67-69

  Mohseni, H ^a   Truong, P ^a,b   Hadjseyd, M ^a   Grimonpont, A ^a   Dieny, A ^a   Mechin Cretinon, I ^a   Chabert, P ^a  

^a CENTRE HOSPITALIER   (France)

^b CENTRE HOSPITALIER DE CHAMBÉRY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; TAMOXIFEN;

ADENOCARCINOMA; AGED; ARTICLE; AXILLARY LYMPH NODE; BONE PAIN; BREAST CARCINOMA; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CURETTAGE; DEATH; FEMALE; FEMORAL NERVE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; HYSTEROSCOPY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; METRORRHAGIA; OVARIECTOMY; OVARY; OVARY METASTASIS; PELVIS TUMOR; PERITONEUM EXUDATE; SYMPTOM; ULTRASOUND; UTERUS BIOPSY; UTERUS CANCER; BIOPSY; BREAST TUMOR; LUNG CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; OVARY TUMOR; PATHOLOGY; TIME;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST NEOPLASMS; CARCINOMA, LOBULAR; DIPHOSPHONATES; FEMALE; HUMANS; HYSTERECTOMY; HYSTEROSCOPY; LYMPH NODES; LYMPHATIC METASTASIS; OVARIAN NEOPLASMS; TAMOXIFEN; TIME FACTORS; UTERINE NEOPLASMS;

EID: 0037452312     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Afriat R, Lenain H, Vuagnat C et al. Métastase d'un cancer du sein dans un léiomyome utérin. J Gynecol Obstet Biol Reprod 1993; 22: 243-4.
2. Le Bouedec G, Kauffmann Ph, De Latour M, Fondrinier E, Cure H, Dauplat J. Métastases utérines des cancers du sein. À propos de 8 observations. J Gynecol Obstet Biol Reprod 1991; 20: 349-54.
3. Sinkre P, Milchgrub S, Miller DS, Albores-Saavedra J, Hameed A. Case report: Uterine metastasis from a heterologous metaplastic breast carcinoma simulating a primary uterine malignancy. Gynecologic Oncology 2000; 77: 216-18.
4. Stemmermann GN. Extrapelvic carcinoma metastatic to the uterus. Am J Obstet Gynecol 1967; 82: 1261-6.
5. Sugiyama T, Toyoda N, Nose J, Kihira N, Ando Y, Ishihara A. Breast cancer metastatic to uterine leiomyoma: a case report. J Obstet Gynaecol Res 1995; 21: 349-55.
6. Martinez-Montero I, Dominguez-Cunchillos F, Murizabal JC, De Miguel C, Recari E, Ezcurdia M. Case reports: Uterine metastases from breast cancer. Acta Obstet Gynecol Scand 1999; 78: 165-8.
7. Krulik M. Tumeurs de Krükenberg et métastases ovariennes du cancer du sein. Presse Med 1997; 26: 452-3.
8. Le Bouedec G, De Latour M, Levrel O, Dauplat J. Tumeurs de Krükenberg d'origine mammaire. 10 observations. Presse Med 1997; 2: 454-7.
9. Perry Louise J, Lewis JC, Ball RY. Case report Adenocarcinoma of the breast metastatic to benign ovarian fibroma. Gynecologic Oncology 1996; 62: 408-10.
10. Ishioka S, Sagae S, Kobayashi K, Sugimura M, Nishioka Y, Kudo R. A case of simultaneous presence of primary endometrial carcinoma and metastasis of a breast carcinoma to the ovary after 5 years of tamoxifen therapy. J Obstet Gynaecol Res 1999; 25: 113-17.